World News: 13:20 GMT Thursday 23rd May 2019. [XBiotech Inc. via Globe Newswire via SPi World News]
AUSTIN Texas May 23 2019 GLOBE NEWSWIRE --NASDAQ XBIT announced plans to its dermatology program for its true human antibody bermekimab with the of a randomized double-blind placebo controlled Phase 2b clinical study i...
Globe Newswire: 13:20 GMT Thursday 23rd May 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.